Aspermont Ret. on equity
What is the Ret. on equity of Aspermont?
The Ret. on equity of Aspermont Limited is -62.68%
What is the definition of Ret. on equity?
Return on equity is a measure of the profitability of a business in relation to the book value of the shareholder equity. It is computed by dividing fiscal year net income by total shareholder equity.
ttm (trailing twelve months)
The return on equity (ROE) ROE is a measure of how well a company uses investments to generate earnings growth. ROE is used for comparing the performance of companies in the same industry. It indicated the management's ability to generate income from the equity available to it. ROEs of 15-20% are generally considered good. ROEs are also a factor in stock valuation, in association with other financial ratios. In general, stock prices are influenced by earnings per share (EPS), so that stock of a company with a 20% ROE will generally cost twice as much as one with a 10% ROE.
Ret. on equity of companies in the Communication Services sector on ASX compared to Aspermont
What does Aspermont do?
Aspermont Limited provides media services to resource industries in Australia, Asia, Europe, the United States, and internationally. It also provides publications, researches, and events, as well as other publications in partnership with external agencies across various trade sectors, including mining, investment, agriculture, and energy. In addition, the company offers online publications that provide news and information directly on desktops, tablets, and smart phones, as well as print publications through tablet and mobile apps. Further, it organizes events and conferences. Aspermont Limited was incorporated in 1961 and is based in Perth, Australia.
Companies with ret. on equity similar to Aspermont
- Lamtex has Ret. on equity of -62.94%
- Valaris plc has Ret. on equity of -62.90%
- KRM22 Plc has Ret. on equity of -62.88%
- Key Petroleum has Ret. on equity of -62.88%
- Ideal Power Inc has Ret. on equity of -62.80%
- Weebit Nano has Ret. on equity of -62.70%
- Aspermont has Ret. on equity of -62.68%
- Raunaq EPC International has Ret. on equity of -62.65%
- Cardiff Oncology has Ret. on equity of -62.65%
- Ovoca Bio plc has Ret. on equity of -62.65%
- Ovoca Bio plc has Ret. on equity of -62.65%
- Editas Medicine Inc has Ret. on equity of -62.61%
- Blink Charging Co has Ret. on equity of -62.59%